Professional
Added to YB: 2026-10-14
Pitch date: 2026-10-01
ACON [bullish]
Aclarion, Inc.
-21.09%
current return
Author Info
Trickle Research is an independent microcap research firm. Visit the website.
Company Info
Aclarion, Inc. operates as a healthcare technology company in the United States. It uses magnetic resonance spectroscopy (MRS) combined with proprietary signal-processing biomarkers to optimize clinical treatments.
Market Cap
$6.7M
Pitch Price
$2.48
Price Target
7.75 (+297%)
Dividend
N/A
EV/EBITDA
1.01
P/E
-0.38
EV/Sales
-114.01
Sector
Health Care Technology
Category
growth
Trickle Research -Initiating Coverage - Aclarion, Inc. (ACON)
ACON: Aclarion’s NOCISCAN could fill the need for a noninvasive test identifying pain-generating lumbar discs, but the thesis depends on CLARITY validating improved surgical outcomes and unlocking reimbursement and adoption beyond the limited provocative-discography market. Preliminary data are due in 1H27; prior observational results and coverage from three major U.K. insurers support optimism. The 12-24-month target is $7.75, with weak trial results, continued cash burn and future equity raises the main risks.
Read full article (40 min)